Biogened S.A.

Informe acción WSE:BGD

Capitalización de mercado: zł54.0m

Salud financiera de hoja de balance de Biogened

Salud financiera controles de criterios 4/6

Biogened tiene un patrimonio de accionistas total de PLN39.3M y una deuda total de PLN23.3M, lo que sitúa su ratio deuda-patrimonio en 59.2%. Sus activos y pasivos totales son PLN87.0M y PLN47.7M respectivamente. El BAIT de Biogened es de PLN8.4M, por lo que su ratio de cobertura de intereses es de 3.7. Tiene efectivo e inversiones a corto plazo que ascienden a PLN6.2M.

Información clave

59.2%

Ratio deuda-patrimonio

zł23.29m

Deuda

Ratio de cobertura de intereses3.7x
Efectivozł6.16m
Patrimoniozł39.32m
Total pasivozł47.66m
Activos totaleszł86.97m

Actualizaciones recientes sobre salud financiera

Recent updates

Biogened (WSE:BGD) Takes On Some Risk With Its Use Of Debt

Nov 06
Biogened (WSE:BGD) Takes On Some Risk With Its Use Of Debt

A Piece Of The Puzzle Missing From Biogened S.A.'s (WSE:BGD) 25% Share Price Climb

Aug 28
A Piece Of The Puzzle Missing From Biogened S.A.'s (WSE:BGD) 25% Share Price Climb

Impressive Earnings May Not Tell The Whole Story For Biogened (WSE:BGD)

Aug 22
Impressive Earnings May Not Tell The Whole Story For Biogened (WSE:BGD)

Investors Give Biogened S.A. (WSE:BGD) Shares A 37% Hiding

May 23
Investors Give Biogened S.A. (WSE:BGD) Shares A 37% Hiding

Here's Why Biogened (WSE:BGD) Has A Meaningful Debt Burden

May 09
Here's Why Biogened (WSE:BGD) Has A Meaningful Debt Burden

Biogened's (WSE:BGD) Promising Earnings May Rest On Soft Foundations

Feb 21
Biogened's (WSE:BGD) Promising Earnings May Rest On Soft Foundations

Is Biogened (WSE:BGD) A Risky Investment?

Feb 01
Is Biogened (WSE:BGD) A Risky Investment?

Biogened S.A. (WSE:BGD) Looks Just Right With A 37% Price Jump

Feb 01
Biogened S.A. (WSE:BGD) Looks Just Right With A 37% Price Jump

We Think Biogened (WSE:BGD) Can Stay On Top Of Its Debt

Jun 30
We Think Biogened (WSE:BGD) Can Stay On Top Of Its Debt

Biogened (WSE:BGD) Seems To Use Debt Quite Sensibly

Oct 08
Biogened (WSE:BGD) Seems To Use Debt Quite Sensibly

Is Biogened (WSE:BGD) A Risky Investment?

Jun 29
Is Biogened (WSE:BGD) A Risky Investment?

Does Biogened (WSE:BGD) Have A Healthy Balance Sheet?

Mar 25
Does Biogened (WSE:BGD) Have A Healthy Balance Sheet?

These 4 Measures Indicate That Biogened (WSE:BGD) Is Using Debt Reasonably Well

Dec 09
These 4 Measures Indicate That Biogened (WSE:BGD) Is Using Debt Reasonably Well

Biogened (WSE:BGD) Has A Somewhat Strained Balance Sheet

Jul 29
Biogened (WSE:BGD) Has A Somewhat Strained Balance Sheet

Biogened (WSE:BGD) Seems To Use Debt Quite Sensibly

Apr 30
Biogened (WSE:BGD) Seems To Use Debt Quite Sensibly

Is Biogened (WSE:BGD) A Risky Investment?

Jan 24
Is Biogened (WSE:BGD) A Risky Investment?

Análisis de la situación financiera

Pasivos a corto plazo: Los activos a corto plazo (PLN52.7M) de BGD superan a sus pasivos a corto plazo (PLN23.4M).

Pasivo a largo plazo: Los activos a corto plazo de BGD (PLN52.7M) superan a sus pasivos a largo plazo (PLN24.2M).


Historial y análisis de deuda-patrimonio

Nivel de deuda: La relación deuda neta-capital de BGD (43.6%) se considera alta.

Reducción de la deuda: El ratio deuda-patrimonio de BGD ha crecido de 40.6% a 59.2% en los últimos 5 años.

Cobertura de la deuda: La deuda de BGD está bien cubierta por el flujo de caja operativo (20.1%).

Cobertura de intereses: Los pagos de intereses de la deuda de BGD están bien cubiertos por el BAIT (3.7x cobertura).


Hoja de balance


Descubre empresas con salud financiera